SFDA CEO discusses challenges facing Indian pharma plants to enter Saudi market

03/11/2023 Argaam
SFDA CEO meeting with Indian pharma industry representatives

SFDA CEO meeting with Indian pharma industry representatives

Hisham Aljadhey, CEO of the Saudi Food and Drug Authority (SFDA), discussed the challenges facing Indian pharmaceutical factories to enter the Saudi market, increase products, and find appropriate solutions, Saudi Press Agency reported.

 

This came during Aljadhey meeting with pharmaceutical, food and medical device companies in the Indian capital, New Delhi, in the presence of representatives of the Indian Pharmaceutical Export Promotion Council, the Indian Pharmaceutical Alliance, and Agricultural and Processed Food Products Export Development Authority.

 

Aljadhey discussed opportunities for cooperation in relevant research studies, in addition to opportunities to develop new techniques in biotechnology.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.